SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Benchmarks and NC ONEcare Partner in North Carolina
The two organizations will work together to advocate for better health outcomes for children and families in North Carolina.
Mishe Announces Omnichannel Pharmacy Network
The network will work with DiRx and MakoRX.
Pfizer Makes Publicis New Global Creative Duties Partner
The news comes less than a year after Pfizer announced that IPG would handle this role.
Researchers Present First Study Using Biomimetic AI Digital Twins
The study used technology developed by a variety of companies, including RYLTI.
Adapting to Remote Workers and Services: Q&A with Rebecca Marquez, Director of Custom Research at PMMI
Marquez discusses the results of a recent survey about how elements of the industry are reacting to a post remote-work world.
Minnesota Bill Would Increase Access to Genetic Testing
The bill would remove financial for genetic testing determined to be clinically appropriate.
FDA Grants 501(k) to Two Avicenna.AI Products
Both products are designed to help radiologists.
CSL Behring and Takeda Discuss Advancing Clinical Development and the Future of Trials
The conversation took place during the Veeva R&D Summit in Boston.
Deerfield Agency Appoints Bill Veltre as Executive Vice President and Head of Media
Veltre will develop the company’s media and digital strategy.
Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)
Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.
The Regulatory Consequences of the Mifepristone Case: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics
Alexander discusses the broader implications the case could have on FDA's ability to regulate the industry.
AbbVie to Acquire Landos Biopharma
The move will bring Landos’ lead drug, NX-13, under AbbVie’s umbrella.
Eli Lilly Announces Shortage for Certain Insulin Formations in April
The shortage is due to a reported manufacturing interruption.
Medicare to Cover Wegovy for Certain Indications
The drug was recently cleared to treat cardiovascular risks, making it eligible for Medicare Part D.
CDC Releases Health Alert and Pushes for Increase in Measles Vaccinations
The agency released guidelines for vaccinations guidelines for children as young as 6 months old.
Research Lab Unveils Tool to Improve Clinical Trial Participation
Cold Spring Harbor Laboratory details how the new tool will help reduce common barriers to trial participation.
Breaking Down the Inflation Reduction Act: Q&A with Alice Valder Curran, Partner at Hogan Lovells
Valder Curran discusses recent developments with the IRA.
OncoHost Wins AI Excellence Award
The technology platform won the award for its work using AI to improve precision medicine.
Cambrex Plans to Complete $100 Million Investment Strategy Earlier Then Planned
The company will see the completion of its projects about a year earlier than expected.
AstraZeneca Announces Plans to Acquire Fusion
The acquisition will bolster AstraZeneca’s ability to develop radioconjugates for cancer treatments.
Lunit Expands AI Cancer Screening to France and Portugal
The company’s software will be used to help with chest and breast cancer screenings.
New Report Shows AI Improved Treatments for Biofilm Infections
The technology was used to develop new peptides.
Deadly Brain Tumors May Be Treatable with New CAR-T Therapy, Study Suggests
The therapies are still in the early stages of development, but researchers are optimistic about the results.
BeiGene and Leukemia & Lymphoma Society Sign Three Year Agreement
As part of the partnership, BeiGene will serve as a sponsor at LLS events.
Eli Lilly Partners with Amazon Pharmacy
The online retailer will be able to provide customers with a selection of migraine, obesity, and diabetes medications.
ADHD Medication May Reduce Mortality Among Patients, New Study Suggests
The study, out of Sweden, researched the impact of the use of medication and mortality rates for patients with ADHD.
AION Labs Launches New Platform to Reduce Time and Cost of Antibody Development
The platform will allow for a more direct method of antibody optimization.
Bringing Real World Data to Clinical Studies: Q&A With Dr. David Cosgrove of Compass Oncology
Cosgrove discusses how a recent study utilized a high-tech data platform to bring a new perspective on data to the researchers.
Par Pharmaceutical Issues Recall of Single Lot of Treprostinil
The voluntary recall was ordered due to potential silicon particulate exposure.
Investing in Stability: Q&A With James Sapirstein, CEO of First Wave BioPharma
Sapirstein discusses the current conditions that are impacting investors’ view of the life sciences industry.